A dynamic view of comorbid depression and generalized anxiety disorder symptom change in chronic heart failure: The discrete effects of cognitive behavioral therapy, exercise, and psychotropic medication

Disability and Rehabilitation

Volumn 37, Issue 7, 2015, Pages 585-592

  Tully, Phillip J ^a,b,c   Selkow, Terina ^c   Bengel, Jürgen ^b   Rafanelli, Chiara ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anti depressant; Anxiolytic; Cognitive behavioral therapy; Exercise major depression disorder; Generalized anxiety disorder; Heart failure

Indexed keywords

ADULT; AGED; ANXIETY DISORDERS; AUSTRALIA; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPLICATION; DEPRESSIVE DISORDER; DRUG THERAPY; FEMALE; HEART FAILURE; HOSPITAL READMISSION; HUMAN; KINESIOTHERAPY; MALE; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE;

ADULT; AGED; ANXIETY DISORDERS; CHRONIC DISEASE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; DRUG THERAPY; EXERCISE THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; SOUTH AUSTRALIA; SURVEYS AND QUESTIONNAIRES;

EID: 84924454831     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2014.935493     Document Type: Article

References (71)

1. McMurray JJV, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 2012;14:803-69.
2. Stewart S, MacIntyre K, Hole DJ, et al. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22.
3. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Col Cardiol 2006;48:1527-37.
4. Ketterer MW, Draus C, McCord J, et al. Behavioral factors and hospital admissions/readmissions in patients with CHF. Psychosomatics 2014;55:45-50.
5. Smith DH, Johnson ES, Blough DK, et al. Predicting costs of care in heart failure patients. BMC Health Serv Res 2012;12:434.
6. Samartzis L, Dimopoulos S, Tziongourou M, Nanas S. Effect of psychosocial interventions on quality of life in patients with chronic heart failure: a meta-analysis of randomized controlled trials. J Cardiac Fail 2013;19:125-34.
7. Jaarsma T, Lesman-Leegte I, Hillege HL, et al. Depression and the usefulness of a disease management program in heart failure. Insights From the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) Study. J Am Col Cardiol 2010;55:1837-43.
8. Izawa KP, Watanabe S, Oka K, et al. Association between mental health and physical activity in patients with chronic heart failure. Disabil Rehabil 2014;36:250-4.
9. National Heart Lung and Blood Institute. What is heart failure? Available from: http://www.nhlbi.nih.gov/health/health-topics/topics/hf/[last accessed 15 Oct 2013].
10. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatr 1998;20:29-43.
11. Gellis ZD, Kang-Yi C. Meta-analysis of the effect of cardiac rehabilitation interventions on depression outcomes in adults 64 years of age and older. Am J Cardiol 2012;110:1219-24.
12. Pizzi C, Rutjes AW, Costa GM, et al. Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol 2011;107:972-9.
13. Dowlati Y, Herrmann N, Swardfager WL, et al. Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Can J Psychiatr 2010;55: 91-9.
14. Woltz PC, Chapa DW, Friedmann E, et al. Effects of interventions on depression in heart failure: a systematic review. Heart Lung 2012; 41:469-83.
15. Rimer J, Dwan K, Lawlor DA, et al. Exercise for depression. Cochrane Database Syst Rev 2012;7:CD004366.
16. Kostis JB, Rosen RC, Cosgrove NM, et al. Nonpharmacologic therapy improves functional and emotional status in congestive heart failure. Chest 1994;106:996-1001.
17. Dickens C, Cherrington A, Adeyemi I, et al. Characteristics of psychological interventions that improve depression in people with coronary heart disease: a systematic review and meta-regression. Psychosom Med 2013;75:211-21.
18. Whalley B, Thompson DR, Taylor RS. Psychological interventions for coronary heart disease: cochrane systematic review and meta-analysis. Int J Behav Med 2014;21:109-21.
19. Rutledge T, Redwine LS, Linke SE, Mills PJ. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 2013;75:335-49.
20. Hans E, Hiller W. A meta-analysis of nonrandomized effectiveness studies on outpatient cognitive behavioral therapy for adult anxiety disorders. Clin Psychol Rev 2013;33:954-64.
21. Ladwig KH, Lederbogen F, Albus C, et al. Position paper on the importance of psychosocial factors in cardiology: update 2013. Ger Med Sci 2014;12:Doc09. doi: 10.3205/000194.
22. Lichtman JH, Bigger Jr JT, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008;118:1768-75.
23. Hasnain M, Vieweg WVR, Lesnefsky EJ, Pandurangi AK. Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines. J Psychosom Res 2011;71:6-12.
24. Huffman JC, Mastromauro CA, Beach SR, et al. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med 2014;174: 927-36.
25. Haworth JE, Moniz-Cook E, Clark AL, et al. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 2005;7:803-8.
26. Coventry PA, Bower P, Keyworth C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One 2013;8:e60532.
27. Norweg A, Collins EG. Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD. Int J Chron Obstruct Pulmon Dis 2013;8:439-51.
28. Koenig HG. Differences between depressed patients with heart failure and those with pulmonary disease. Am J Geriatr Psychiatry 2006;14:211-19.
29. Isaksen K, Morken IM, Munk PS, Larsen AI. Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation. Eur J Prev Cardiol 2012;19:804-12.
30. Asmundson GJ, Fetzner MG, Deboer LB, et al. Let's get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depress Anxiety 2013;30:362-73.
31. DeBoer LB, Powers MB, Utschig AC, et al. Exploring exercise as an avenue for the treatment of anxiety disorders. Expert Rev Neurother 2012;12:1011-22.
32. Sherbourne CD, Jackson CA, Meredith LS, et al. Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med 1996;5:27-34; discussion 35.
33. Tully PJ, Cosh SM. Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: a meta analysis. J Health Psychol 2013;18:1601-16.
34. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008;65:62-71.
35. Scherrer JF, Chrusciel T, Zeringue A, et al. Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed veterans administration patients. Am Heart J 2010; 159:772-9.
36. Tully PJ, Pedersen SS, Winefield HR, et al. Cardiac morbidity risk and depression and anxiety: a disorder, symptom and trait analysis among cardiac surgery patients. Psychol Health Med 2011;16: 333-45.
37. Yook K, Kim KH, Suh SY, Lee KS. Intolerance of uncertainty, worry, and rumination in major depressive disorder and generalized anxiety disorder. J Anxiety Disord 2010;24:623-8.
38. Olatunji BO, Wolitzky-Taylor KB, Sawchuk CN, Ciesielski BG. Worry and the anxiety disorders: a meta-analytic synthesis of specificity to GAD. Appl Prevent Psychol 2010;14:1-24.
39. Brosschot JF, Gerin W, Thayer JF. The perseverative cognition hypothesis: a review of worry, prolonged stress-related physiological activation, and health. J Psychosom Res 2006;60:113-24.
40. Tully PJ, Cosh SM, Baune BT. A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease. Psychol Health Med 2013;18: 627-44.
41. Foley A, Hillier S, Barnard R. Effectiveness of once-weekly gym-based exercise programmes for older adults post discharge from day rehabilitation: a randomised controlled trial. Br J Sports Med 2011; 45:978-86.
42. Singh MA. Exercise comes of age: rationale and recommendations for a geriatric exercise prescription. J Gerontol A Biol Sci Med Sci 2002;57:M262-82.
43. Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010;32:345-59.
44. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
45. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
46. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc.; 1997.
47. First MB, Williams JBW, Spitzer RL, Gibbon M. Structured clinical interview for DSM-IV-TR Axis I disorders, clinical trials version (SCID-I/P W/psychotic screen). ed. New York: Biometrics Research; 2007.
48. Burg MM, Rieckmann N, Clemow L, et al. Treatment preferences among depressed patients after acute coronary syndrome: the COPES observational cohort. Psychother Psychosom 2011;80: 380-2.
49. Padesky CA, Greenberger D. Clinician's guide to mind over mood. New York (NY): Guilford Press; 1995.
50. Clinical Research Unit for Anxiety Disorders. Generalized anxiety disorder patient treatment manual. Sydney, NSW: St. Vincent's Hospital Sydney; 2010.
51. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
52. Dekker RL, Moser DK, Peden AR, Lennie TA. Cognitive therapy improves three-month outcomes in hospitalized patients with heart failure. J Card Fail 2012;18:10-20.
53. Jiang W, Krishnan R, Kuchibhatla M, et al. Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol 2011;107:545-51.
54. Gary RA, Dunbar SB, Higgins MK, et al. Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res 2010;69:119-31.
55. Jiang W, O'Connor C, Silva SG, et al. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J 2008; 156:437-44.
56. Kronish IM, Chaplin WF, Rieckmann N, et al. The effect of enhanced depression care on anxiety symptoms in acute coronary syndrome patients: findings from the COPES trial. Psychother Psychosom 2012;81:245-7.
57. Blumenthal JA, Sherwood A, Babyak MA, et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Col Cardiol 2012;60:1053-63.
58. Broadbent E, Ellis CJ, Thomas J, et al. Further development of an illness perception intervention for myocardial infarction patients: a randomized controlled trial. J Psychosom Res 2009;67: 17-23.
59. Michalsen A, Grossman P, Lehmann N, et al. Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial. Psychother Psychosom 2005;74: 344-52.
60. Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial of the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry 2011;72:168-74.
61. Huffman JC, Beach SR, Suarez L, et al. Design and baseline data from the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized controlled trial. Contemp Clin Trials 2013; 36:488-501.
62. Pedersen SS. Post-traumatic stress disorder in patients with coronary artery disease: a review and evaluation of the risk. Scand J Psychol 2001;42:445-51.
63. Tully PJ, Baune BT. Comorbid anxiety disorders alter the association between cardiovascular diseases and depression: the German National Health Interview and Examination Survey. Soc Psych Psychiatr Epidemiol 2014;49:683-91.
64. Carney R, Freedland K. Is there a high-risk subtype of depression in patients with coronary heart disease? Curr Psychiatry Rep 2012;14: 1-7.
65. Shemesh E, Koren-Michowitz M, Yehuda R, et al. Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics 2006;47:231-9.
66. Grenier S, Potvin O, Hudon C, et al. Twelve-month prevalence and correlates of subthreshold and threshold anxiety in community-dwelling older adults with cardiovascular diseases. J Affect Disorder 2012;136:724-32.
67. Cornelius B, van der Klink JJL, Brouwer S, Groothoff JW. Under-recognition and under-treatment of DSM-IV classified mood and anxiety disorders among disability claimants. Disabil Rehabil 2014;36:1161-8.
68. Smolderen KG, Buchanan D, Amin A, et al. Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients: implications for the American Heart Association Depression Screening Advisory. Circulation: Cardiovasc Qual Outcomes 2011;4:283-92.
69. Szczepańska-Gieracha J, Kowalska J, Pawik M, Rymaszewska J. Evaluation of a short-term group psychotherapy used as part of the rehabilitation process in nursing home patients. Disabil Rehabil 2014;36:1027-32.
70. Tully PJ, Wittert GA, Selkow T, Baumeister H. The real world mental health needs of heart failure patients are not reflected by the depression randomized controlled trial evidence. PLoS One 2014;9: e85928.
71. Roncella A, Pristipino C, Cianfrocca C, et al. One-year results of the randomized, controlled, short-term psychotherapy in acute myocar-dial infarction (STEP-IN-AMI) trial. Int J Cardiol 2014;170:132-9.